phase readout
saveNCT04543617: A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy
ACTIVE_NOT_RECRUITINGupdated 1d ago
community read0 votes
Sponsor: Hoffmann-La Roche. Phase: PHASE3. Conditions: Esophageal Squamous Cell Carcinoma
view source ↗
comments(0)
5-min edit window · permanent after that